Moderna to pay up to $2.3 bn to settle COVID vaccine technology dispute with Genevant and ArbutusSee details
Moderna - MRNA - stock price prediction, stock price target, analyst ratings from 24 analysts
Moderna has a share price target of US$ 43, revenue growth forecast of 6.3%, and profit growth estimate of 3.0% for FY26, based on top 24 analyst calls.